ARCHIMED
Bryan Alterman is a seasoned finance professional with extensive experience in private equity and investment roles. Currently serving as Director at ARCHIMED since June 2023, Bryan previously held the position of Principal at Acacia Research from January 2021 to March 2023, focusing on acquiring undervalued businesses in various sectors. Earlier career highlights include Investment Professional at Bessemer Investors and Private Equity Associate at WindRose Health Investors. Beginning with an Analyst role at Moelis & Company and a Buyer position at Macy's Inc., Bryan has built a strong foundation in finance. Bryan holds a Bachelor of Arts in Economics with a concentration in Finance from the University of Virginia.
This person is not in any teams
This person is not in any offices
ARCHIMED
1 followers
With offices in Europe, North America and APAC, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Biopharma Products, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services. ARCHIMED manages €7 billion across its various funds, including the largest healthcare-only private equity fund raised by a European-based General Partner. Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation.